Why is Ind-Swift falling/rising?

As of 01-Aug, Ind-Swift Ltd's stock price is currently at 16.45, reflecting a decrease of 0.33, or 1.97%. The stock has recently experienced a trend reversal, falling after three consecutive days of gains. In terms of performance, it has outperformed its sector by 1.19% today, but its one-week return is down by 3.24%. Over the past year, the stock has significantly underperformed, with a return of -36.04%, compared to the benchmark Sensex, which has only declined by 1.55%. The company is facing challenges, including a negative book value and weak long-term growth, with net sales growing at an annual rate of only 9.01% and operating profit stagnating at 0%. Additionally, the company has a high debt-to-equity ratio and reported negative results in its latest quarter, which have contributed to its current stock price decline.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has fallen more sharply than the overall market, which has seen a return of -4.13% over the past year. The pharmaceuticals and drugs sector, to which Ind-Swift belongs, has also declined by 3.26%, indicating a challenging environment for the industry. Furthermore, there has been a decrease in investor participation, with delivery volume falling by 7.99% against the five-day average, suggesting reduced interest in the stock. Overall, the combination of negative financial indicators, sector performance, and declining investor engagement has contributed to the stock's downward movement.